Trinity Health System, CommonSpirit Health 3rd Annual Cardiovascular Symposium, Innovating for Equity in Community Cardiovascular Care
Learning Objectives
1. Enhance Understanding of Cardiovascular Innovations: Provide attendees with the latest advancements in cardiovascular diagnostics and treatments, focusing on innovative tools and techniques that address traditional challenges in cardiovascular care.
2. Promote Health Equity in Cardiovascular Care: Explore strategies to improve access to cardiovascular care in underserved communities, emphasizing the importance of equitable healthcare delivery and the role of community engagement.
3. Foster Collaborative Learning and Networking: Encourage interaction among healthcare professionals, researchers, and industry leaders to share knowledge, discuss challenges, and develop collaborative solutions for improving cardiovascular health outcomes.
Program agenda
7 a.m. Registration, breakfast, and visit vendors
8 a.m. Opening Remarks - Triston Smith MD, FSCAI, Kelly Bettem FACHE
Session 1 – New Tools to defeat old foes? Moderator: John Schirger MD FACC
8:10 – 8:30 a.m. Pulmonary Embolism – Lyse, Fragment or Suction_James D’Antonio MD
• Objective 1: Evaluate the effectiveness of different interventional techniques for managing pulmonary embolism.
• Objective 2: Discuss the clinical decision-making process for selecting appropriate treatment modalities based on patient-specific factors
8:35 – 8:55 a.m. No more Heart Failure Interventional HF Monitoring and Treatment_Dr. Munir Janmohamed Dignity Health Sacramento
• Objective 1: Present the latest interventional approaches for monitoring and treating heart failure.
• Objective 2: Analyze the potential impact of these innovations on reducing heart failure-related hospitalizations and improving patient quality of life.
9:00 – 9:20 a.m. Refractory Hypertension Let’s Denervate!!!_ Gregory Suero MD FSCAI
• Objective 1: Explore the role of renal denervation in managing refractory hypertension.
• Objective 2: Assess the long-term outcomes and safety profile of renal denervation as a treatment option.
9:25 – 9:45 a.m. Lp(a) Is it worth the hype?_ Muhammad Khalid MD FACC
• Objective 1: Examine the clinical significance of lipoprotein(a) in cardiovascular risk assessment.
• Objective 2: Discuss emerging therapies targeting Lp(a) and their potential role in cardiovascular disease prevention
Panelists: TBD
9:50 –10:00 a.m. Break and Vendor Visits
Session 2 – New Frontiers in Interventions_Moderator: Gregory Suero MD FSCAI
10:00 – 10:20 a.m. Cardiac CTA. From anatomy to physiology and beyond_ Vimal Ramjee. MD Chattanooga Heart Institute
• Objective 1: Highlight the advancements in cardiac CTA technology and its applications in cardiovascular diagnostics.
• Objective 2: Discuss the integration of anatomical and physiological data from CTA in clinical decision-making.
10:25 – 10:45 a.m. Carotid stenting. Are we there yet?_ Victor Maevsky MD
• Objective 1: Review the current evidence and guidelines for carotid stenting in stroke prevention.
• Objective 2: Evaluate the challenges and future directions in optimizing carotid stenting outcomes.
10:50 – 11:10 a.m. Transcatheter Aortic Valve Replacement. Can Aortic Stenosis really be asymptomatic?_ Anu Tunguntla
• Objective 1: Discuss the indications and outcomes of TAVR in asymptomatic aortic stenosis patients.
• Objective 2: Analyze the implications of early intervention in asymptomatic patients on long-term cardiovascular health.
11:15 – 11:35 a.m. Let it go. Let it Gooooo.!!! Updates in Left Atrial Appendage Occlusion_ Muhammad Yasin MD FSCAI
• Objective 1: Present the latest updates and techniques in left atrial appendage occlusion for stroke prevention in atrial fibrillation.
• Objective 2: Evaluate the safety and efficacy of different occlusion devices and their impact on patient outcomes
11:40 – 12:00 p.m. Ablate or wait? Ablation first strategy for atrial and ventricular arrhythmias.
• Objective 1: Assess the clinical outcomes and benefits of using ablation as a first-line treatment strategy for managing atrial and ventricular arrhythmias compared to traditional treatment approaches.
• Objective 2: Identify the key factors and criteria for selecting patients who would benefit most from an ablation-first strategy, including risk assessment and potential complications.
Panelists: TBD
12:05 p.m – 12:55 p.m. Lunch Lunch Satellite Program
Session 3 – Moderated Poster Session_Moderator: Triston Smith MD
1 – 1:45 p.m. 5 Posters. Each presenter gets 5 minutes to present. 3-minute Q and A
1:45 – 1:55 p.m. Hands only CPR/EHAC - Gregory Suero MD FSCAI and Brandon Bolduc PA
2:00 – 2:45 p.m. Hypertrophic Cardiomyopathy. Current challenges and solutions. Srihari Naidu MD FSCAI
• Objective 1: Explore the current challenges in diagnosing and managing hypertrophic cardiomyopathy.
• Objective 2: Discuss innovative solutions and therapies that address these challenges and improve patient care.
2:45 – 3:00 p.m. Break and visit vendors.
Session 4 – Fireside Chat
3:00 – 4:00 p.m. Fireside Chat with Author and SCAI Vice President Srihari Naidu about his Children’s book Lindsay’s Big Heart and his Classic Comic Collection: Triston Smith MD MGM FSCAI
• Objective 1: Gain insights into the creative process and inspiration behind the children's book "Lindsay’s Big Heart."
• Objective 2: Discuss the role of storytelling and comics in patient education and engagement in cardiovascular health.
4:00 – 4:15 p.m. Concluding Remarks – CEO Trinity Health, CommonSpirit Health, Matthew Colflesh CMO
4:15 – 5:00 p.m. Networking
Program times, topics, and speakers subject to change!!!!
In support of improving patient care, this activity has been planned and implemented by the University of Pittsburgh and Trinity Health System. The University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The University of Pittsburgh designates this live activity for a maximum of 6.75 AMA PRA Category 1 Credit[s]™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
Available Credit
- 6.75 AMA PRA Category 1 Credit™The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
- 6.75 Attendance